{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T07:13:52Z","timestamp":1726470832938},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Crohn's and Colitis"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.crohns.2012.06.016","type":"journal-article","created":{"date-parts":[[2012,7,18]],"date-time":"2012-07-18T21:51:35Z","timestamp":1342648295000},"page":"e143-e145","source":"Crossref","is-referenced-by-count":7,"title":["Anti-tumor necrosis factor-\u03b1 induced systemic lupus erythematosus in a patient with metastatic Crohn's disease\u2014what is the role of anti-TNF antibody?"],"prefix":"10.1093","volume":"7","author":[{"given":"Klaudia","family":"Farkas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferenc","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tibor","family":"Wittmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tam\u00e1s","family":"Moln\u00e1r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1016\/j.crohns.2012.06.016_bb0005","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/MPG.0b013e3181837289","article-title":"Drug-induced lupus associated with infliximab and adalimumab in an adolescent with Crohn disease","volume":"49","author":"Zella","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.crohns.2012.06.016_bb0115","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","article-title":"Autoimmune diseases induced by TNF-targeted therapies. Analysis of 233 cases","volume":"86","author":"Ramos-Casals","year":"2007","journal-title":"Medicine"},{"key":"10.1016\/j.crohns.2012.06.016_bb0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/ard.2004.024182","article-title":"Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha","volume":"64","author":"Eriksson","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.crohns.2012.06.016_bb0020","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.4049\/jimmunol.167.12.6821","article-title":"In vivo neutralization of TNF-alpha promotes humoral autoimmunity by preventing the induction of CTL","volume":"167","author":"Via","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.crohns.2012.06.016_bb0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.gastro.2003.10.047","article-title":"The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients","volume":"126","author":"Colombel","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2012.06.016_bb0030","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1007\/BF02236866","article-title":"Metastatic Crohn's disease. Case report of an unusual variant and review of the literature","volume":"43","author":"Guest","year":"2000","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.crohns.2012.06.016_bb0120","doi-asserted-by":"crossref","first-page":"871567","DOI":"10.1155\/2009\/871567","article-title":"Metastatic Crohn's disease of the ear","volume":"2009","author":"Chuah","year":"2009","journal-title":"Int J Otolaryngol"},{"key":"10.1016\/j.crohns.2012.06.016_bb0040","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1007\/s10620-006-9533-2","article-title":"Metastatic Crohn's disease of the face","volume":"51","author":"Graham","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.crohns.2012.06.016_bb0045","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2133.1976.tb00868.x","article-title":"Metastatic Crohn's disease","volume":"95","author":"McCallum","year":"1976","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.crohns.2012.06.016_bb0050","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s00296-004-0467-8","article-title":"The effect of infliximab on extraintestinal manifestations of Crohn's disease","volume":"25","author":"Kaufman","year":"2005","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.crohns.2012.06.016_bb0055","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1365-2036.2009.03955.x","article-title":"Review article: anti TNF-a induced psoriasis in patients with inflammatory bowel disease","volume":"29","author":"Fiorino","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2012.06.016_bb0060","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-4632.2011.04871.x","article-title":"TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists","volume":"50","author":"Williams","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.crohns.2012.06.016_bb0065","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMoa020888","article-title":"Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease","volume":"348","author":"Baert","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.crohns.2012.06.016_bb0070","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/gut.2009.183095","article-title":"Trough serum infliximab: a predictive factor of clinical outcome for infliximab therapy in acute ulcerative colitis","volume":"59","author":"Seow","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2012.06.016_bb0075","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/ibd.21839","article-title":"Trough levels and antibodies to infliximab may not predict response to intensification of infliximab therapy in patients with inflammatory bowel disease.","volume":"18","author":"Pariente","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.crohns.2012.06.016_bb0080","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00054725-200305000-00005","article-title":"A lupus-like syndrome associated with infliximab therapy","volume":"9","author":"Klapman","year":"2003","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.crohns.2012.06.016_bb0085","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.semarthrit.2007.08.003","article-title":"Drug-induced lupus due to anti-tumor necrosis factor alpha agents","volume":"37","author":"Costa","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.crohns.2012.06.016_bb0090","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1365-2133.2011.10555.x","article-title":"Autoantibodies in psoriasis as predictors for loss of response and anti-infliximab antibody induction","volume":"165","author":"Hoffmann","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.crohns.2012.06.016_bb0125","first-page":"507","article-title":"The sera of patients with Klebsiella infections contain a common anti-DNA idiotype (16\/6) Id and anti-polynucleotide activity","volume":"67","author":"El-Roiey","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.crohns.2012.06.016_bb0100","first-page":"36","article-title":"Comparative study of NZB mice under germ-free and conventional conditions","volume":"2","author":"Unni","year":"1975","journal-title":"J Rheumatol"},{"key":"10.1016\/j.crohns.2012.06.016_bb0130","doi-asserted-by":"crossref","first-page":"683489","DOI":"10.1155\/2008\/683489","article-title":"A possible link between infection with Burkholderia bacteria and systemic lupus erythematosus based on epitope mimicry","volume":"2008","author":"Zhang","year":"2008","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.crohns.2012.06.016_bb0110","doi-asserted-by":"crossref","first-page":"329","DOI":"10.5858\/arpa.2010-0666-RS","article-title":"Metastatic Crohn's disease: a rare cutaneous entity","volume":"136","author":"Siroy","year":"2012","journal-title":"Arch Pathol Lab Med"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994612002991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994612002991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/7\/4\/e143\/1093707\/7-4-e143.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T18:02:07Z","timestamp":1503424927000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-lookup\/doi\/10.1016\/j.crohns.2012.06.016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1873994612002991"],"URL":"https:\/\/doi.org\/10.1016\/j.crohns.2012.06.016","relation":{},"ISSN":["1873-9946"],"issn-type":[{"type":"print","value":"1873-9946"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}